Miss

Kate

Linton

School of Medicine and Population Health

Senior University Teacher in Medical Education

k.linton@sheffield.ac.uk

The Medical School

Full contact details

Miss Kate Linton

School of Medicine and Population Health

The Medical School

Beech Hill Road

Sheffield

S10 2RX

Profile

For enquiries please contact - SMPH-West-Operational@sheffield.ac.uk

I qualified from the University of Sheffield in 1997. Following basic surgical training in Sheffield I performed research in the field of prostate cancer metastasis towards an MD thesis at the University of Sheffield. I undertook urological training within the Yorkshire and Humber deanery and was appointed as a consultant urologist in 2013. In 2016 I commenced work as a senior university teacher and also work as a consultant urologist at Chesterfield Royal Hospital. I oversee the prescribing and pharmacology strand within the MBChB course.

Research interests

Medical students views on prescribing teaching. Milestone based assessment of medical students' patient assessment skills.

Current projects:

Milestone based assessment of medical students' patient assessment skills

Publications

Journal articles

Hughes M, Linton KD, Sykes A, Rosario DP & Din OS (2025) Prospective analysis of patient reported outcomes following rectal spacer insertion prior to Prostate radiotherapy. Clinical Oncology, 38.
Conroy S, Jubber I, Noon AP, Rosario DJ, Griffin J, Morgan S, Hubbard R, Kennish S, Mitchell S, Venugopal S , Linton K et al (2025) Real-word outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial. BJU International, 135(2), 329-338. View this article in WRRO
Linton KD & Murdoch-Eaton D (2020) Twelve tips for facilitating medical students prescribing learning on clinical placement. Medical Teacher, 42(10), 1134-1139.
Rouprêt M, Morgan TM, Bostrom PJ, Cooperberg MR, Kutikov A, Linton KD, Palou J, Martínez-Piñeiro L, van der Poel H, Wijburg C , Winterbottom A et al (2014) European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media. European Urology, 66(4), 628-632.
Linton KD & Woo HH (2014) Complications of prostate cancer treatment. The Lancet Oncology, 15(4), e150-e151.
Linton KD & Catto JW (2013) Upper tract urothelial carcinoma. Journal of Clinical Urology, 6(5), 272-279.
Linton KD & Hall J (2013) Obstruction of the upper and lower urinary tract. Surgery (Oxford), 31(7), 346-353.
Linton KD & Catto JWF (2013) Prostate cancer. Surgery (Oxford), 31(10), 516-522.
Linton KD, Rosario DJ, Thomas F, Rubin N, Goepel JR, Abbod MF & Catto JWF (2013) Disease Specific Mortality in Patients with Low Risk Bladder Cancer and the Impact of Cystoscopic Surveillance. Journal of Urology, 189(3), 828-833.
Linton KD & Catto JWF (2012) Whole-body Magnetic Resonance Imaging and Prostate Cancer Metastases: A New Gold Standard of Detection, But Does It Help Us and At What Cost?. European Urology, 62(1), 76-77.
Linton KD, Rosario DJ, Thomas F, Rubin N, Abbod MF & Catto JWF (2012) 1043 Routine cystoscopic surveillance is ineffective in preventing death due to bladder cancer in patients with low risk disease. European Urology Supplements, 11(1), e1043-e1043a.
Malki M, Linton KD, Mackinnon R & Hall J (2012) Conservative management of pelvi‐ureteric junction obstruction (PUJO): is it appropriate and if so what duration of follow‐up is needed?. BJU International, 110(3), 446-448.
Linton KD, Rosario DJ, Thomas F, Rubin N, Abbod MF & Catto JWF (2012) Routine cystoscopic surveillance is ineffective in preventing death due to bladder cancer in patients with low risk disease. EUROPEAN UROLOGY SUPPLEMENTS, 11(1), E1043-EU179.
Mangera A, Linton KD, Fernando M, Channer J & Chapple CR (2012) What is the evidence for the management of urethral amyloidosis? A systematic review of the literature. BJU International, 109(12), 1858-1861.
Linton KD & Catto JWF (2011) Re: Comorbidity and Mortality Results from a Randomised Prostate Cancer Screening Trial. European Urology, 60(4), 867-867.
Linton KD & Catto JWF (2011) Gastrointestinal Toxicity Following Radiotherapy for Prostate Cancer: A Ring of Fire. European Urology, 60(5), 917-919.
Linton KD & Catto JWF (2011) Gastrointestinal Toxicity Following Radiotherapy for Prostate Cancer: A Ring of Fire. European Urology.
Tophill PR & Linton KD (2010) Letter to the Editor on ‘Sildenafil in spinal cord injury’ by Khorrami et al. (2009). International Journal of Andrology, 33(6), 865-865.
Linton KD & Hall J (2010) Obstruction of the upper and lower urinary tract. Surgery (Oxford), 28(7), 331-337.
Linton KD & Wylie KR (2010) Recent advances in the treatment of premature ejaculation. Drug Design, Development and Therapy, 4, 1-6. View this article in WRRO
Cross NA, Fowles A, Reeves K, Jokonya N, Linton K, Holen I, Hamdy FC & Eaton CL (2008) Imaging the effects of castration on bone turnover and hormone‐independent prostate cancer colonization of bone. The Prostate, 68(15), 1707-1714.
Hall J & Linton KD (2008) Obstruction of the upper and lower urinary tract. Surgery (Oxford), 26(5), 197-202.
Collins A, Hyde K, Berry P, Linton K, Hamdy F, Stower M & Maitland N (2006) α2β 1HI/CD133+ PROSTATE CANCER STEM CELLS FROM HUMAN TUMOURS ARE HIGHLY TUMORIGENIC IN VIVO. European Urology Supplements, 5(14), 790-790.
Linton KD & Hamdy FC (2003) Early diagnosis and surgical management of prostate cancer. Cancer Treatment Reviews, 29(3), 151-160.
Linton K, Bath AP & Lee JA (1998) Tonsillar metastasis from malignant pulmonary carcinoid tumour. The Journal of Laryngology & Otology, 112(6), 581-583.

Book chapters

Eaton CL, Linton KD & Hamdy FC (2006) Bone-Directed Therapy in Prostate Cancer: Rationale and Novel Approaches, Translational Medicine (pp. 223-236). Informa Healthcare

Conference proceedings

Malki M, Linton KD, MacKinnon R & Hall J (2011) Conservative management of pelvi-ureteric junction obstruction (PUJO): is it appropriate and if so how long is follow-up needed?. BJU INTERNATIONAL, Vol. 108 (pp 48-48)
Malki MM, Linton KD, Mackinnon R & Hall J (2011) CONSERVATIVE MANAGEMENT OF PELVI-URETERIC JUNCTION OBSTRUCTION (PUJO): IS IT APPROPRIATE AND IF SO HOW LONG IS FOLLOW-UP NEEDED?. JOURNAL OF ENDOUROLOGY, Vol. 25 (pp A54-A54)

Teaching interests: Prescribing and medication safety, Urology

Teaching activities

In foundation clinical skills I teach on how to examine the GI/GU system as well as on how to take a medication history/prescribing.

In Phase 3b and Phase 4 I teach on prescribing, drug errors and prescribing safety assessment preparation.

I am keen to incorporate prescribing learning into all clinical encounters for student doctors.

Professional activities and memberships: I currently oversee the pharmacology and prescribing strand which spans the whole MBChB course and I am academic lead for the Prescribing Safety Assessment (PSA) in Sheffield. I am a question writer and peer reviewer for the PSA.